In bladder urothelial carcinoma, RIPK4 was shown to exhibit a high level and its silence inhibited the tumor growth and migration of bladder urothelial carcinoma cells via modulating NF-κB pathway [13]. This evidence concerns the gene NFKB1 and neoplasm.